Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

FLECAINIDE ACETATE

12 general benefit · 2 not a benefit

Other products in the same Health Canada class (C01B, C01BC) — coverage varies; not interchangeable

  • Propafenone (Rythmol): general benefit
  • Amiodarone (Cordarone): general benefit, Not a benefit
  • Disopyramide (Norpace): general benefit, Not a benefit, Listing status unconfirmed
  • Mexiletine (Mexitil): general benefit, Not a benefit

Apo-Flecainide · DIN 02275538 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Flecainide · DIN 02275538 Manufacturer: Apotex Inc.; listing date 2006-07-19 Health Canada: Marketed since 2017-12-15 · brand APO-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Flecainide: Formulary list price $0.1389/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1389 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76117 · Verify on the e-Formulary ↗ (DIN 02275538)

Source record
DIN 02275538: Apo-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id APX Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1389; ministry $0.1389 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02275538 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76117
Interchangeable products
Auro-Flecainide · DIN 02459957 · $0.1389 Flecainide · DIN 02534800 · $0.1389 Jamp Flecainide · DIN 02493705 · $0.1389 Mar-Flecainide · DIN 02476177 · $0.1389 NRA-Flecainide · DIN 02530066 · $0.1389 Tambocor · DIN 01966197 · not recorded
Shortage status: resolved shortage (ended 2025-10-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02275538
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Auro-Flecainide · DIN 02459957 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Flecainide · DIN 02459957 Manufacturer: Auro Pharma Inc.; listing date 2017-11-30 Health Canada: Marketed since 2017-02-27 · brand AURO-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Auro-Flecainide: Formulary list price $0.1389/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1389 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94726 · Verify on the e-Formulary ↗ (DIN 02459957)

Source record
DIN 02459957: Auro-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id AUR Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1389; ministry $0.1389 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02459957 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94726
Interchangeable products
Apo-Flecainide · DIN 02275538 · $0.1389 Flecainide · DIN 02534800 · $0.1389 Jamp Flecainide · DIN 02493705 · $0.1389 Mar-Flecainide · DIN 02476177 · $0.1389 NRA-Flecainide · DIN 02530066 · $0.1389 Tambocor · DIN 01966197 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02459957
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Flecainide · DIN 02534800 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Flecainide · DIN 02534800 Manufacturer: Sanis Health Inc.; listing date 2023-12-29 Health Canada: Marketed since 2023-10-24 · brand FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Flecainide: Formulary list price $0.1389/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1389 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102370 · Verify on the e-Formulary ↗ (DIN 02534800)

Source record
DIN 02534800: Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id SAI Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1389; ministry $0.1389 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02534800 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102370
Interchangeable products
Apo-Flecainide · DIN 02275538 · $0.1389 Auro-Flecainide · DIN 02459957 · $0.1389 Jamp Flecainide · DIN 02493705 · $0.1389 Mar-Flecainide · DIN 02476177 · $0.1389 NRA-Flecainide · DIN 02530066 · $0.1389 Tambocor · DIN 01966197 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02534800
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Flecainide · DIN 02493705 · 50mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Flecainide · DIN 02493705 Manufacturer: Jamp Pharma Corporation; listing date 2021-01-29 Health Canada: Marketed since 2020-10-27 · brand JAMP FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Flecainide: Formulary list price $0.1389/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1389 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98370 · Verify on the e-Formulary ↗ (DIN 02493705)

Source record
DIN 02493705: Jamp Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id JPC Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1389; ministry $0.1389 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02493705 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98370
Interchangeable products
Apo-Flecainide · DIN 02275538 · $0.1389 Auro-Flecainide · DIN 02459957 · $0.1389 Flecainide · DIN 02534800 · $0.1389 Mar-Flecainide · DIN 02476177 · $0.1389 NRA-Flecainide · DIN 02530066 · $0.1389 Tambocor · DIN 01966197 · not recorded
Shortage status: active shortage (reported 2025-10-31, estimated to end 2026-07-17, last updated 2026-06-16); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02493705
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Flecainide · DIN 02275546 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Flecainide · DIN 02275546 Manufacturer: Apotex Inc.; listing date 2006-07-19 Health Canada: Marketed since 2017-12-15 · brand APO-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Flecainide: Formulary list price $0.2779/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2779 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76118 · Verify on the e-Formulary ↗ (DIN 02275546)

Source record
DIN 02275546: Apo-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id APX Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2779; ministry $0.2779 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02275546 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76118
Interchangeable products
Auro-Flecainide · DIN 02459965 · $0.2779 Flecainide · DIN 02534819 · $0.2779 Jamp Flecainide · DIN 02493713 · $0.2779 Mar-Flecainide · DIN 02476185 · $0.2779 NRA-Flecainide · DIN 02530074 · $0.2779 Tambocor · DIN 01966200 · not recorded
Shortage status: resolved shortage (ended 2024-12-12); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02275546
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Auro-Flecainide · DIN 02459965 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Flecainide · DIN 02459965 Manufacturer: Auro Pharma Inc.; listing date 2017-11-30 Health Canada: Marketed since 2017-02-27 · brand AURO-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Auro-Flecainide: Formulary list price $0.2779/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2779 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94727 · Verify on the e-Formulary ↗ (DIN 02459965)

Source record
DIN 02459965: Auro-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id AUR Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2779; ministry $0.2779 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02459965 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94727
Interchangeable products
Apo-Flecainide · DIN 02275546 · $0.2779 Flecainide · DIN 02534819 · $0.2779 Jamp Flecainide · DIN 02493713 · $0.2779 Mar-Flecainide · DIN 02476185 · $0.2779 NRA-Flecainide · DIN 02530074 · $0.2779 Tambocor · DIN 01966200 · not recorded
Shortage status: resolved shortage (ended 2024-06-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02459965
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Flecainide · DIN 02534819 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Flecainide · DIN 02534819 Manufacturer: Sanis Health Inc.; listing date 2023-12-29 Health Canada: Marketed since 2023-10-24 · brand FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Flecainide: Formulary list price $0.2779/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2779 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102371 · Verify on the e-Formulary ↗ (DIN 02534819)

Source record
DIN 02534819: Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id SAI Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2779; ministry $0.2779 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02534819 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=102371
Interchangeable products
Apo-Flecainide · DIN 02275546 · $0.2779 Auro-Flecainide · DIN 02459965 · $0.2779 Jamp Flecainide · DIN 02493713 · $0.2779 Mar-Flecainide · DIN 02476185 · $0.2779 NRA-Flecainide · DIN 02530074 · $0.2779 Tambocor · DIN 01966200 · not recorded
Shortage status: resolved shortage (ended 2025-01-22); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02534819
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp Flecainide · DIN 02493713 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Flecainide · DIN 02493713 Manufacturer: Jamp Pharma Corporation; listing date 2021-01-29 Health Canada: Marketed since 2020-11-13 · brand JAMP FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp Flecainide: Formulary list price $0.2779/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2779 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98371 · Verify on the e-Formulary ↗ (DIN 02493713)

Source record
DIN 02493713: Jamp Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id JPC Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2779; ministry $0.2779 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02493713 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98371
Interchangeable products
Apo-Flecainide · DIN 02275546 · $0.2779 Auro-Flecainide · DIN 02459965 · $0.2779 Flecainide · DIN 02534819 · $0.2779 Mar-Flecainide · DIN 02476185 · $0.2779 NRA-Flecainide · DIN 02530074 · $0.2779 Tambocor · DIN 01966200 · not recorded
Shortage status: resolved shortage (ended 2023-02-17); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02493713
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mar-Flecainide · DIN 02476177 · 50mg · tablet

General benefitDormant since 2023-10-24 · checked 2026-09-02 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mar-Flecainide · DIN 02476177 Manufacturer: Marcan Pharmaceuticals Inc.; listing date 2021-03-29 Health Canada: Dormant since 2023-10-24 · brand MAR-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Marcan pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Mar-Flecainide: Formulary list price $0.1389/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1389 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96719 · Verify on the e-Formulary ↗ (DIN 02476177)

Source record
DIN 02476177: Mar-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id MAR Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1389; ministry $0.1389 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02476177 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96719
Interchangeable products
Apo-Flecainide · DIN 02275538 · $0.1389 Auro-Flecainide · DIN 02459957 · $0.1389 Flecainide · DIN 02534800 · $0.1389 Jamp Flecainide · DIN 02493705 · $0.1389 NRA-Flecainide · DIN 02530066 · $0.1389 Tambocor · DIN 01966197 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02476177
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2023-10-24 — choose a marketed DIN from the same-category list.

Mar-Flecainide · DIN 02476185 · 100mg · tablet

General benefitDormant since 2024-01-17 · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mar-Flecainide · DIN 02476185 Manufacturer: Marcan Pharmaceuticals Inc.; listing date 2021-03-29 Health Canada: Dormant since 2024-01-17 · brand MAR-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Marcan pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Mar-Flecainide: Formulary list price $0.2779/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2779 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96720 · Verify on the e-Formulary ↗ (DIN 02476185)

Source record
DIN 02476185: Mar-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id MAR Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2779; ministry $0.2779 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02476185 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96720
Interchangeable products
Apo-Flecainide · DIN 02275546 · $0.2779 Auro-Flecainide · DIN 02459965 · $0.2779 Flecainide · DIN 02534819 · $0.2779 Jamp Flecainide · DIN 02493713 · $0.2779 NRA-Flecainide · DIN 02530074 · $0.2779 Tambocor · DIN 01966200 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02476185
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2024-01-17 — choose a marketed DIN from the same-category list.

Tambocor · DIN 01966197 · 50mg · tablet

Listed, not a benefitDormant since 2021-03-03 · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Tambocor · DIN 01966197 Manufacturer: Graceway Pharmaceuticals; listing date 1996-10-01 Health Canada: Dormant since 2021-03-03 · brand TAMBOCOR · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Bausch health, canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Tambocor: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13513 · Verify on the e-Formulary ↗ (DIN 01966197)

Source record
DIN 01966197: Tambocor Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id GRA Source form: Tab; strength: 50mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01966197 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13513
Interchangeable products
Apo-Flecainide · DIN 02275538 · $0.1389 Auro-Flecainide · DIN 02459957 · $0.1389 Flecainide · DIN 02534800 · $0.1389 Jamp Flecainide · DIN 02493705 · $0.1389 Mar-Flecainide · DIN 02476177 · $0.1389 NRA-Flecainide · DIN 02530066 · $0.1389
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01966197
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2021-03-03 — choose a marketed DIN from the same-category list.

Tambocor · DIN 01966200 · 100mg · tablet

Listed, not a benefitDormant since 2021-03-03 · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Tambocor · DIN 01966200 Manufacturer: Graceway Pharmaceuticals; listing date 1996-10-01 Health Canada: Dormant since 2021-03-03 · brand TAMBOCOR · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Bausch health, canada inc. · schedule Prescription
Check this DIN again · Health Canada product record

Tambocor: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13514 · Verify on the e-Formulary ↗ (DIN 01966200)

Source record
DIN 01966200: Tambocor Raw flags: chronicUseMed=Y, notABenefit=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id GRA Source form: Tab; strength: 100mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01966200 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13514
Interchangeable products
Apo-Flecainide · DIN 02275546 · $0.2779 Auro-Flecainide · DIN 02459965 · $0.2779 Flecainide · DIN 02534819 · $0.2779 Jamp Flecainide · DIN 02493713 · $0.2779 Mar-Flecainide · DIN 02476185 · $0.2779 NRA-Flecainide · DIN 02530074 · $0.2779
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01966200
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2021-03-03 — choose a marketed DIN from the same-category list.

NRA-Flecainide · DIN 02530066 · 50mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.Discontinued 2024-10-21 · checked 2026-09-02
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
NRA-Flecainide · DIN 02530066 Manufacturer: Nora Pharma; listing date 2023-07-31 Health Canada: Cancelled post market since 2024-10-21 · brand NRA-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 50 MG · company Nora pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

NRA-Flecainide: Formulary list price $0.1389/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1389 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101927 · Verify on the e-Formulary ↗ (DIN 02530066)

Source record
DIN 02530066: NRA-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400119; group id 282; item number 0601; lccId None; manufacturer id NRA Source form: Tab; strength: 50mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.1389; ministry $0.1389 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02530066 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101927
Interchangeable products
Apo-Flecainide · DIN 02275538 · $0.1389 Auro-Flecainide · DIN 02459957 · $0.1389 Flecainide · DIN 02534800 · $0.1389 Jamp Flecainide · DIN 02493705 · $0.1389 Mar-Flecainide · DIN 02476177 · $0.1389 Tambocor · DIN 01966197 · not recorded
Shortage status: discontinued (2024-09-01, reported by NORA PHARMA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02530066
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.

NRA-Flecainide · DIN 02530074 · 100mg · tablet

General benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.Discontinued 2024-10-21 · checked 2026-09-02
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
NRA-Flecainide · DIN 02530074 Manufacturer: Nora Pharma; listing date 2023-07-31 Health Canada: Cancelled post market since 2024-10-21 · brand NRA-FLECAINIDE · ATC C01BC04 FLECAINIDE · form Tablet · route Oral · ingredients FLECAINIDE ACETATE 100 MG · company Nora pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

NRA-Flecainide: Formulary list price $0.2779/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2779 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101928 · Verify on the e-Formulary ↗ (DIN 02530074)

Source record
DIN 02530074: NRA-Flecainide Raw flags: chronicUseMed=Y, sec3=Y Item: 240400095; group id 282; item number 0602; lccId None; manufacturer id NRA Source form: Tab; strength: 100mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2779; ministry $0.2779 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02530074 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101928
Interchangeable products
Apo-Flecainide · DIN 02275546 · $0.2779 Auro-Flecainide · DIN 02459965 · $0.2779 Flecainide · DIN 02534819 · $0.2779 Jamp Flecainide · DIN 02493713 · $0.2779 Mar-Flecainide · DIN 02476185 · $0.2779 Tambocor · DIN 01966200 · not recorded
Shortage status: discontinued (2024-09-01, reported by NORA PHARMA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02530074
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2024-10-21 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (24:04 Cardiac Drugs) and how they are covered

Matched class: 24:04 Cardiac Drugs

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ATENOLOL, DIGOXIN, PROPAFENONE HCL Some products covered without a code (check the product listing): ACEBUTOLOL HCL, AMIODARONE HCL, AMLODIPINE, BISOPROLOL FUMARATE, DILTIAZEM HCL, DISOPYRAMIDE, METOPROLOL TARTRATE, MEXILETINE HCL, NADOLOL, NIFEDIPINE, PROPRANOLOL, SOTALOL HCL, TIMOLOL MALEATE, VERAPAMIL HCL 24:00 CARDIOVASCULAR DRUGS

RANOLAZINE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · ER Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:00 24:04 Cardiac Drugs

PROPAFENONE HCL

· 6 products · General benefit · strengths: 150mg, 300mg · Tab

AMIODARONE HCL

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 200mg · Tab

DISOPYRAMIDE

· 3 products · Listed, not a benefit (1), General benefit (1), Temporary benefit (1) · strengths: 100mg · Cap

MEXILETINE HCL

· 6 products · Listed, not a benefit (2), General benefit (4) · strengths: 100mg, 200mg · Cap

ACEBUTOLOL HCL

· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 100mg, 200mg, 400mg · Tab

AMLODIPINE

· 56 products · Limited Use, codes 645, 706 (1), Off-Formulary Interchangeable, not an ODB benefit (11), General benefit (44) · strengths: 1mg/mL, 2.5mg, 5mg, 10mg · Oral Sol, Tab

ATENOLOL

· 26 products · General benefit · strengths: 50mg, 100mg · Tab

BISOPROLOL FUMARATE

· 20 products · General benefit (18), Listed, not a benefit (2) · strengths: 1.25mg, 2.5mg, 5mg, 10mg · Tab

DIGOXIN

· 7 products · General benefit · strengths: 0.05mg/mL, 0.0625mg, 0.125mg · O/L, Tab

DILTIAZEM HCL

· 93 products · General benefit (91), Listed, not a benefit (2) · strengths: 120mg, 180mg, 240mg, 300mg, 360mg, 30mg, 60mg · ER Tab, LA Cap, SR Cap, Tab

METOPROLOL TARTRATE

· 28 products · Listed, not a benefit (6), General benefit (22) · strengths: 100mg, 200mg, 50mg · LA Tab, Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 24:04 and 9 more
Full class listing Related classes: 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 Indications In patients without structural heart disease and with disabling symptoms, APO-FLECAINIDE is indicated for the prevention of: • paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal re-entrant tachycardia, atrioventricular re-entrant tachycardia and other supraventricular tachycardias of unspecified mechanism, • paroxysmal atrial fibrillation/flutter (PAF). Patients treated with APO-FLECAINIDE for supraventricular arrhythmias having impaired left ventricular function (ejection fraction < 40) and/or ischemic heart disease may be at increased risk for cardiac adverse reactions. Use of APO-FLECAINIDE in chronic atrial fibrillation has not been adequately studied and is not recommended (see 3 Serious Warnings and Precautions Box). APO-FLECAINIDE is also indicated for the treatment of: • documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgement of the physician, are life-threatening. • Because of the proarrhythmic effects of APO-FLECAINIDE, its use should be reserved for patients in whom, in the opinion of the physician, the benefits… https://pdf.hres.ca/dpd_pm/00083156.PDF PM date: JAN 13, 2026 Source product: APO-FLECAINIDE; DIN 02275538; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Jamp Flecainide · DIN 02493705 Shortage status: active shortage (reported 2025-10-31, estimated to end 2026-07-17, last updated 2026-06-16); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02493705

Check this DIN again

NRA-Flecainide · DIN 02530066 Shortage status: discontinued (2024-09-01, reported by NORA PHARMA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02530066

Check this DIN again

NRA-Flecainide · DIN 02530074 Shortage status: discontinued (2024-09-01, reported by NORA PHARMA INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02530074

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Tambocor: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026